← Issue №18/ week of Nov 1, 2026/Motility

Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients.

From GI Signals issue №18: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Motility retrospective · n=3,508 · Oct 27, 2026 · Aliment Pharm Ther · IF 6.7

Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients.

New evidencebasic scienceepidemiologybiomarker
Clinical takeawayAvoid routine quantification of mast cells in colonic biopsies for patients with chronic diarrhoea or nonspecific abdominal symptoms, as it does not correlate with symptom presence.
What it foundDiarrhoea prevalence was similar across mast cell (MC) count groups: 58.3% (<20 MC/hpf), 54.1% (20-39 MC/hpf), 54.7% (40-59 MC/hpf), 50.0% (60-98 MC/hpf), and 33.3% (≥99 MC/hpf), compared to standard diagnostic approaches.
ContextChallenges the practice of incorporating mast cell quantification into histologic evaluation for common GI symptoms, which has been controversial due to unclear clinical relevance. This recommendation applies to patients with chronic diarrhoea or nonspecific abdominal symptoms.
Emergingsuggested applicable standard· British Society of Gastroenterology, Arasaradnam RP, et al. "Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition." Gut, 2018;67(8):1380-1399.

In an adult with chronic diarrhoea (loose or watery stools persisting >4 weeks) and a macroscopically normal colonoscopy, take biopsies from BOTH the right (proximal) and left (distal) colon to exclude microscopic colitis; because microscopic colitis has a patchy distribution, one-sided (e.g. rectosigmoid-only) biopsies are no longer recommended. …

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

In an adult with chronic diarrhoea (loose or watery stools persisting >4 weeks) and a macroscopically normal colonoscopy, take biopsies from BOTH the right (proximal) and left (distal) colon to exclude microscopic colitis; because microscopic colitis has a patchy distribution, one-sided (e.g. rectosigmoid-only) biopsies are no longer recommended. Investigation is tiered rather than a fixed panel. First-line screening (primary care): full blood count, ferritin, CRP, coeliac serology (anti-tTG), thyroid function, and faecal calprotectin, with stool culture, the screening bloods/coeliac/faecal-inflammation tests carry a strong recommendation. If first-line tests are normal and symptoms persist, secondary-care testing is directed by the clinical picture: SeHCAT or fasting serum 7α-hydroxy-4-cholesten-3-one (C4) for suspected bile acid diarrhoea, faecal elastase for pancreatic exocrine insufficiency, lactose/hydrogen breath testing for carbohydrate maldigestion, and, for suspected SIBO, an empirical trial of antibiotics, which the guideline recommends as the practical approach (strong recommendation) because there is insufficient evidence to recommend routine hydrogen or methane breath testing and it does not endorse jejunal aspirate as the routine preferred test. A functional/IBS diagnosis is appropriate when there are typical functional symptoms, a normal examination, and normal screening investigations; younger patients (<40) with atypical or persistent symptoms warrant specialist review even if faecal calprotectin is normal.

British Society of Gastroenterology, Arasaradnam RP, et al. "Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition." Gut, 2018;67(8):1380-1399. · reviewed 2026-07-23 ↗
Langreiter M … Schreiner P · Alimentary Pharmacology & Therapeutics · IF 6.7 · PubMed ↗Permalink
← Read the whole of issue №18 Every paper GI Signals surfaces gets a page like this one. All issues